<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Yang H</submitter><funding>NIGMS NIH HHS</funding><pubmed_abstract>&lt;b>Background.&lt;/b> Severe COVID-19 is characterized by pro-inflammatory cytokine release syndrome (cytokine storm) which causes high morbidity and mortality. Recent observational and clinical studies suggest famotidine, a histamine 2 receptor (H2R) antagonist widely used to treat gastroesophageal reflux disease , attenuates the clinical course of COVID-19. Because evidence is lacking for a direct antiviral activity of famotidine, a proposed mechanism of action is blocking the effects of histamine released by mast cells. Here we hypothesized that famotidine activates the inflammatory reflex, a brain-integrated vagus nerve mechanism which inhibits inflammation via alpha 7 nicotinic acetylcholine receptor ( α7nAChR ) signal transduction, to prevent cytokine storm. &lt;b>Methods.&lt;/b> The potentia</pubmed_abstract><journal>Research square</journal><pagination>rs.3.rs-1493296</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9016653</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm.</pubmed_title><pmcid>PMC9016653</pmcid><funding_grant_id>R35 GM118182</funding_grant_id><funding_grant_id>R01 GM132672</funding_grant_id><pubmed_authors>Yang H</pubmed_authors><pubmed_authors>Tynan A</pubmed_authors><pubmed_authors>Andersson U</pubmed_authors><pubmed_authors>Tracey KJ</pubmed_authors><pubmed_authors>Chang E</pubmed_authors><pubmed_authors>Pavlov VA</pubmed_authors><pubmed_authors>Tsaava T</pubmed_authors><pubmed_authors>Chavan SS</pubmed_authors><pubmed_authors>Brines M</pubmed_authors><pubmed_authors>George SJ</pubmed_authors><pubmed_authors>Thompson D</pubmed_authors><pubmed_authors>Silverman HA</pubmed_authors></additional><is_claimable>false</is_claimable><name>Famotidine activates the vagus nerve inflammatory reflex to attenuate cytokine storm.</name><description>&lt;b>Background.&lt;/b> Severe COVID-19 is characterized by pro-inflammatory cytokine release syndrome (cytokine storm) which causes high morbidity and mortality. Recent observational and clinical studies suggest famotidine, a histamine 2 receptor (H2R) antagonist widely used to treat gastroesophageal reflux disease , attenuates the clinical course of COVID-19. Because evidence is lacking for a direct antiviral activity of famotidine, a proposed mechanism of action is blocking the effects of histamine released by mast cells. Here we hypothesized that famotidine activates the inflammatory reflex, a brain-integrated vagus nerve mechanism which inhibits inflammation via alpha 7 nicotinic acetylcholine receptor ( α7nAChR ) signal transduction, to prevent cytokine storm. &lt;b>Methods.&lt;/b> The potentia</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Apr</publication><modification>2025-04-04T19:09:57.427Z</modification><creation>2025-02-19T01:24:02.616Z</creation></dates><accession>S-EPMC9016653</accession><cross_references><pubmed>35441176</pubmed><doi>10.21203/rs.3.rs-1493296/v1</doi></cross_references></HashMap>